Radical Ovarian Cancer Treatment
Radical Ovarian Cancer Treatment – EARLY results from a new cancer treatment pioneered in Melbourne show that advanced ovarian cancer can be fought to a standstill – an against-the-odds result that could point to a radical new way of beating other cancers.
Researchers from the Royal Women’s Hospital and Monash University say they are increasingly excited about the trial, which began last year.
The research comes as new national figures on ovarian cancer showed that almost two-thirds of Australians diagnosed with the disease will not be alive five years later.
Professor Michael Quinn, from the Royal Women’s Hospital’s cancer unit, is leading a team testing ”immune modulation” therapy.
It works on the theory that the immune system has a 10 to 14-day cycle, during which it emits ”inhibitor cells” that stop the body fighting cancer.
The team gives small, tightly targeted chemotherapy doses at exactly the right time in the cycle to block the inhibitor cells and boost the body’s defence against the tumour.
Since last year they have given the therapy to seven women with advanced, recurrent ovarian cancer, while also working with Monash University’s department of immunology to crack the secrets of the immune cycle.
Radical Ovarian Cancer Treatment
Tags: australians, Cancer Unit, Chemotherapy, Immune Cycle, Immune Modulation Therapy, Immunology, Leading A Team, Melbourne Show, Michael Quinn, Monash University, Ovarian Cancer, Ovarian Cancer Treatment, Professor Michael, Recurrent Ovarian Cancer, Right Time, Royal Women, S Hospital, Seven Women, Standstill, Tumour
Posted in Health
No Comments